{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:26:05Z","timestamp":1648920365740},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1331\/japha.2014.13152","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T20:35:37Z","timestamp":1392410137000},"page":"188-192","source":"Crossref","is-referenced-by-count":2,"title":["Guillain-Barr\u00e9 syndrome in an older man following influenza vaccination"],"prefix":"10.1016","volume":"54","author":[{"given":"Natalie A.","family":"Finch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Guarascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1331\/JAPhA.2014.13152_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"24","key":"10.1331\/JAPhA.2014.13152_bb0015","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Nobuhiro","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1331\/JAPhA.2014.13152_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1331\/JAPhA.2014.13152_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1331\/JAPhA.2014.13152_bb0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain-Barr\u00e9 syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009\u20132010","volume":"175","author":"Green","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"33","key":"10.1331\/JAPhA.2014.13152_bb0035","first-page":"1057","article-title":"Estimates of death associated with seasonal influenza \u2014 United States, 1976\u20132007","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1331\/JAPhA.2014.13152_bb0040","doi-asserted-by":"crossref","first-page":"e27622","DOI":"10.1371\/journal.pone.0027622","article-title":"I-MOVE multi-centre case control study 2010\u201311: Overall and stratified estimates of influenza vaccine effectiveness in Europe","volume":"6","author":"Kisslong","year":"2011","journal-title":"PLoS One"},{"issue":"9876","key":"10.1331\/JAPhA.2014.13152_bb0045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barr\u00e9 syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"281","author":"Salmon","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1331\/JAPhA.2014.13152_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amepre.2010.05.022","article-title":"Evaluation of Guillain-Barr\u00e9 syndrome among recipients of influenza vaccine in 2000 and 2001","volume":"39","author":"Burwen","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1331\/JAPhA.2014.13152_bb0055","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institute of Medicine","year":"2012"},{"issue":"9","key":"10.1331\/JAPhA.2014.13152_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","article-title":"Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study","volume":"13","author":"Kwong","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1331\/JAPhA.2014.13152_bb0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/aje\/kws196","article-title":"Guillain-Barr\u00e9 syndrome during the 2009\u20132010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1331\/JAPhA.2014.13152_bb0070","first-page":"1103","article-title":"Cerebrospinal fluid analysis","volume":"68","author":"Seehusen","year":"2003","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1331\/JAPhA.2014.13152_bb0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0028-3886.53282","article-title":"An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain-Barr\u00e9 syndrome","volume":"57","author":"Gonzalez-Quevedo","year":"2009","journal-title":"Neurology India"},{"issue":"50","key":"10.1331\/JAPhA.2014.13152_bb0080","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1016\/j.vaccine.2012.09.074","article-title":"Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"30","author":"Loughlin","year":"2012","journal-title":"Vaccine"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911530162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T17:21:37Z","timestamp":1538846497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431911530162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S154431911530162X"],"URL":"https:\/\/doi.org\/10.1331\/japha.2014.13152","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}